Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia
Alessandro Allegra, Alessandro Tonacci, Caterina Musolino, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19
Sabine Haggenburg, Quincy Hofsink, Birgit I. Lissenberg‐Witte, et al.
JAMA Oncology (2022) Vol. 8, Iss. 10, pp. 1477-1477
Open Access | Times Cited: 62
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
Sabine Haggenburg, Birgit I. Lissenberg‐Witte, Rob van Binnendijk, et al.
Blood Advances (2022) Vol. 6, Iss. 5, pp. 1537-1546
Open Access | Times Cited: 55
Hepatitis E Virus (HEV) Infection Among Immunocompromised Individuals: A Brief Narrative Review
Radostina Alexandrova, Ilia Tsachev, Plamen M. Kirov, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 1021-1040
Open Access | Times Cited: 9
Comorbidities and mortality rate in COVID‐19 patients with hematological malignancies: A systematic review and meta‐analysis
Adel Naimi, Ilya Yashmi, Reza Jebeleh, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 5
Open Access | Times Cited: 35
Depletion of polyfunctional CD26highCD8+ T cells repertoire in chronic lymphocytic leukemia
Najmeh Bozorgmehr, Mark Hnatiuk, Anthea Peters, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 20
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
piRNA associates with immune diseases
Mingye Jiang, Xiaoning Hong, Yunfei Gao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Bendamustine: a review of pharmacology, clinical use and immunological effects (Review)
Hrvoje Lalić, Igor Aurer, Drago Batinić, et al.
Oncology Reports (2022) Vol. 47, Iss. 6
Open Access | Times Cited: 27
Chronic Lymphocytic Leukemia: Time to Care for the Survivors
Pasquale L. Fedele, Stephen Opat
Journal of Clinical Oncology (2024) Vol. 42, Iss. 17, pp. 2005-2011
Closed Access | Times Cited: 5
Practical guidance on the prevention and management of infection in multiple myeloma patients: A case-based approach
Aarthi Kannan, Karen Jeffrey, Siraj Misbah, et al.
Blood Reviews (2025), pp. 101287-101287
Open Access
Influence of Vitamin D and Its Analogues in Type-B Lymphomas
Valerio Basile, Alessandro Allegra, Herbert Marini, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 135-135
Open Access
Selinexor’s Immunomodulatory Impact in Advancing Multiple Myeloma Treatment
Kereshmeh Tasbihi, Heiko Bruns
Cells (2025) Vol. 14, Iss. 6, pp. 430-430
Open Access
Patient-reported outcomes with subcutaneous immunoglobulin in secondary immunodeficiency
Juthaporn Cowan, Il‐Kang Na, André Gladiator, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Altered immune cell profiles in blood of mature/peripheral T-cell leukemia/lymphoma patients: an EuroFlow study
F. Javier Morán‐Plata, Noemí Muñoz‐García, Susana Bárrena, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
UiO-based platforms in biomedicine: Advanced nanovehicles for effective treatment
Ren Zhang, Abdulnasser Mahmoud Karami, Qianying Huang, et al.
Materials Today Chemistry (2025) Vol. 45, pp. 102645-102645
Closed Access
The Impact of Curcumin on Immune Response: An Immunomodulatory Strategy to Treat Sepsis
Alessandro Allegra, Giuseppe Mirabile, Roberta Ettari, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14710-14710
Open Access | Times Cited: 17
Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis
Εfstathia Liatsou, Ioannis Ntanasis‐Stathopoulos, Stavros Lykos, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2266-2266
Open Access | Times Cited: 10
Development of a predictive machine learning model for pathogen profiles in patients with secondary immunodeficiency
Qianning Liu, Yifan Chen, Peng Xie, et al.
BMC Medical Informatics and Decision Making (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
IgG testing, immunoglobulin replacement therapy, and infection outcomes in patients with CLL or NHL: real-world evidence
Jacob D. Soumerai, Zaid Yousif, Thais Gift, et al.
Blood Advances (2024) Vol. 8, Iss. 16, pp. 4239-4249
Open Access | Times Cited: 3
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax
Yang Yang, Yamin Shu, Guosong Chen, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0278725-e0278725
Open Access | Times Cited: 15
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies
Maryam Noori, Shadi Azizi, Farhan Abbasi Varaki, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109046-109046
Open Access | Times Cited: 14
Secondary antibody deficiency in chronic lymphocytic leukemia and non-Hodgkin lymphoma: Recommendations from an international expert panel
Stephen Jolles, Sergio Giralt, Tessa Kerre, et al.
Blood Reviews (2022) Vol. 58, pp. 101020-101020
Open Access | Times Cited: 14
Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma
Sergio Giralt, Stephen Jolles, Tessa Kerre, et al.
Clinical Lymphoma Myeloma & Leukemia (2023) Vol. 23, Iss. 10, pp. 719-732
Open Access | Times Cited: 8
Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre
Erica C. Koch Hein, Maysa Vilbert, Ian Hirsch, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4312-4312
Open Access | Times Cited: 8
COVID-19 in Adult Patients with Hematological Malignancies—Lessons Learned after Three Years of Pandemic
Iwona Hus, Agnieszka Szymczyk, Joanna Mańko, et al.
Biology (2023) Vol. 12, Iss. 4, pp. 545-545
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top